Thoma Bravo Announces Closing of EQS Acquisition
Following the closing of the Offer, Thoma Bravo holds a total stake of approx. 98% of the share capital of EQS, which includes all tendered shares, shares acquired on the market, shares subject to the partial re-investment of
About Thoma Bravo
Thoma Bravo is one of the largest software investors in the world, with approximately
Legal Disclaimer
This publication is neither an offer to purchase nor a solicitation of an offer to sell shares in EQS or any other securities.
This publication may contain statements about Thoma Bravo, and/or EQS and/or either of its affiliates that are or may be "forward-looking statements", i.e., statements about processes that take place in the future, not in the past. Forward-looking statements include, without limitation, statements that typically contain words such as "seek", "estimate", "intend", "plan", "believe", "continue", "will", "may", "should", "would", "could", or other words of similar meaning. By their nature, forward-looking statements are based on current expectations, assumptions, estimates and projections and involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and many of which are outside the control of Thoma Bravo, EQS and/or any of its affiliates. Thoma Bravo and EQS caution you that forward-looking statements are not guarantees of the occurrence of such future events or of future performance. Any forward-looking statement speaks only as at the date of this announcement. Except as required by applicable law, Thoma Bravo does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thoma-bravo-announces-closing-of-eqs-acquisition-302051932.html
SOURCE Thoma Bravo
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Joseph Spine Institute Announces New Regenerative Therapy Center, Offering Advanced Adipose-Derived Cell and PRP Therapies
- Lundbeck to highlight mechanistic insights on bexicaserin's dual mode of action at the European Epilepsy Congress
- Monport Highlights Engraving Opportunities as Labor Day and Football Season Begin
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share